These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28155940)

  • 21. Anti-tumor drug delivery system based on cyclodextrin-containing pH-responsive star polymer: in vitro and in vivo evaluation.
    Xiong Q; Zhang M; Zhang Z; Shen W; Liu L; Zhang Q
    Int J Pharm; 2014 Oct; 474(1-2):232-40. PubMed ID: 25149124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. pH-Responsive therapeutic solid lipid nanoparticles for reducing P-glycoprotein-mediated drug efflux of multidrug resistant cancer cells.
    Chen HH; Huang WC; Chiang WH; Liu TI; Shen MY; Hsu YH; Lin SC; Chiu HC
    Int J Nanomedicine; 2015; 10():5035-48. PubMed ID: 26346762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of polymer-lipid nanoparticles for image-guided delivery of dual modality therapy.
    Mieszawska AJ; Kim Y; Gianella A; van Rooy I; Priem B; Labarre MP; Ozcan C; Cormode DP; Petrov A; Langer R; Farokhzad OC; Fayad ZA; Mulder WJ
    Bioconjug Chem; 2013 Sep; 24(9):1429-34. PubMed ID: 23957728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Doxorubicin-loaded polysaccharide nanoparticles suppress the growth of murine colorectal carcinoma and inhibit the metastasis of murine mammary carcinoma in rodent models.
    Li M; Tang Z; Zhang D; Sun H; Liu H; Zhang Y; Zhang Y; Chen X
    Biomaterials; 2015 May; 51():161-172. PubMed ID: 25771007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. pH-sensitive pullulan-doxorubicin nanoparticles loaded with 1,1,2-trichlorotrifluoroethane as a novel synergist for high intensity focused ultrasound mediated tumor ablation.
    Li H; Yu C; Zhang J; Li Q; Qiao H; Wang Z; Zeng D
    Int J Pharm; 2019 Feb; 556():226-235. PubMed ID: 30543892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation of an efficient and safe polymeric-magnetic nanoparticle delivery system for sorafenib in hepatocellular carcinoma.
    Tom G; Philip S; Isaac R; Praseetha PK; Jiji SG; Asha VV
    Life Sci; 2018 Aug; 206():10-21. PubMed ID: 29709652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance.
    Zhang D; Kong YY; Sun JH; Huo SJ; Zhou M; Gui YL; Mu X; Chen H; Yu SQ; Xu Q
    Int J Nanomedicine; 2017; 12():2081-2108. PubMed ID: 28356731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment.
    Pan C; Liu Y; Zhou M; Wang W; Shi M; Xing M; Liao W
    Int J Nanomedicine; 2018; 13():1119-1137. PubMed ID: 29520140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of sorafenib and liposome doxorubicin on human poorly differentiated thyroid carcinoma xenografts in nude mice].
    An CM; Wang Z; Han ZK; Li ZJ; Tang PZ; Ma J
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Nov; 47(11):931-6. PubMed ID: 23302199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amphiphilic peptide dendritic copolymer-doxorubicin nanoscale conjugate self-assembled to enzyme-responsive anti-cancer agent.
    Li N; Li N; Yi Q; Luo K; Guo C; Pan D; Gu Z
    Biomaterials; 2014 Nov; 35(35):9529-45. PubMed ID: 25145854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo evaluation of drug-eluting microspheres designed for transarterial chemoembolization therapy.
    Wang Y; Molin DG; Sevrin C; Grandfils C; van den Akker NM; Gagliardi M; Knetsch ML; Delhaas T; Koole LH
    Int J Pharm; 2016 Apr; 503(1-2):150-62. PubMed ID: 26965198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dendronized heparin-doxorubicin conjugate based nanoparticle as pH-responsive drug delivery system for cancer therapy.
    She W; Li N; Luo K; Guo C; Wang G; Geng Y; Gu Z
    Biomaterials; 2013 Mar; 34(9):2252-64. PubMed ID: 23298778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index.
    Scomparin A; Salmaso S; Eldar-Boock A; Ben-Shushan D; Ferber S; Tiram G; Shmeeda H; Landa-Rouben N; Leor J; Caliceti P; Gabizon A; Satchi-Fainaro R
    J Control Release; 2015 Jun; 208():106-20. PubMed ID: 25869964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles.
    Tao X; Gou J; Zhang Q; Tan X; Ren T; Yao Q; Tian B; Kou L; Zhang L; Tang X
    Biomater Sci; 2018 Jun; 6(7):1869-1881. PubMed ID: 29808221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ceramide-Fabricated Co-Loaded Liposomes for the Synergistic Treatment of Hepatocellular Carcinoma.
    Yin X; Xiao Y; Han L; Zhang B; Wang T; Su Z; Zhang N
    AAPS PharmSciTech; 2018 Jul; 19(5):2133-2143. PubMed ID: 29714002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
    Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
    Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pluronic-based functional polymeric mixed micelles for co-delivery of doxorubicin and paclitaxel to multidrug resistant tumor.
    Chen Y; Zhang W; Huang Y; Gao F; Sha X; Fang X
    Int J Pharm; 2015 Jul; 488(1-2):44-58. PubMed ID: 25899286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A duplex oligodeoxynucleotide-dendrimer bioconjugate as a novel delivery vehicle for doxorubicin in in vivo cancer therapy.
    Lee IH; Yu MK; Kim IH; Lee JH; Park TG; Jon S
    J Control Release; 2011 Oct; 155(1):88-95. PubMed ID: 20854858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous delivery of anti-miR21 with doxorubicin prodrug by mimetic lipoprotein nanoparticles for synergistic effect against drug resistance in cancer cells.
    Rui M; Qu Y; Gao T; Ge Y; Feng C; Xu X
    Int J Nanomedicine; 2017; 12():217-237. PubMed ID: 28115844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic hyperthermia and pH-responsive effective drug delivery to the sub-cellular level of human breast cancer cells by modified CoFe
    Oh Y; Moorthy MS; Manivasagan P; Bharathiraja S; Oh J
    Biochimie; 2017 Feb; 133():7-19. PubMed ID: 27916642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.